Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors
scientific article published on 4 January 2016
Author/s
author: Hagop Kantarjian, Zeev Estrov, Jorge Eduardo Cortes, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Naveen Pemmaraju, Tapan M Kadia, Koji Sasaki, Naval Daver, Rajyalakshmi Luthra, Rashmi Kanagal-shamanna, Graciela M Nogueras-Gonzalez, Preetesh Jain, Carlos Guillermo Romo, Keyur P Patel
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.